1. Home
  2. TROX vs INBX Comparison

TROX vs INBX Comparison

Compare TROX & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tronox Holdings plc (UK)

TROX

Tronox Holdings plc (UK)

HOLD

Current Price

$6.51

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$84.84

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROX
INBX
Founded
2018
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2012
2024

Fundamental Metrics

Financial Performance
Metric
TROX
INBX
Price
$6.51
$84.84
Analyst Decision
Hold
Buy
Analyst Count
8
3
Target Price
$6.36
$150.00
AVG Volume (30 Days)
2.6M
208.6K
Earning Date
05-06-2026
05-15-2026
Dividend Yield
2.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,898,000,000.00
$1,300,000.00
Revenue This Year
$6.94
N/A
Revenue Next Year
$5.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
550.00
52 Week Low
$2.86
$20.57
52 Week High
$10.59
$155.29

Technical Indicators

Market Signals
Indicator
TROX
INBX
Relative Strength Index (RSI) 59.69 46.93
Support Level $6.79 $75.69
Resistance Level $8.61 $85.97
Average True Range (ATR) 0.43 4.34
MACD 0.09 0.44
Stochastic Oscillator 89.87 66.31

Price Performance

Historical Comparison
TROX
INBX

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: